back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-06-24 09:21 Tx date 2024-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-1,930 vol |
20,282 | |
| Filed 2024-06-24 09:21 Tx date 2024-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,633 vol |
22,212 | |
| Filed 2024-06-24 09:19 Tx date 2024-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-5,633 vol |
84,852 | |
| Filed 2024-03-05 15:57 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-3,188 vol |
16,579 | |
| Filed 2024-03-05 15:57 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,422 vol |
19,767 | |
| Filed 2024-03-05 15:56 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-8,422 vol |
90,485 | |
| Filed 2024-03-04 18:27 Tx date 2024-02-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+39,126 vol |
98,907 | |
| Filed 2023-09-07 10:25 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-33,249.70
-3,982 vol $8.35 each |
11,345 | |
| Filed 2023-09-07 10:24 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$97,060
+11,624 vol $8.35 each |
15,327 | |
| Filed 2023-09-07 10:23 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,624 vol |
59,781 | |
| Filed 2023-06-21 16:07 Tx date 2023-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-14,274.60
-1,929 vol $7.40 each |
3,703 | |
| Filed 2023-06-21 16:06 Tx date 2023-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$41,676
+5,632 vol $7.40 each |
5,632 | |
| Filed 2023-06-21 16:04 Tx date 2022-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-21 16:04 Tx date 2023-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-5,632 vol |
71,405 | |
| Filed 2023-03-06 17:46 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+21,812 vol |
21,812 | |
| Filed 2023-03-06 17:45 Tx date 2022-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-06 17:44 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$233,710
+25,266 vol $9.25 each |
77,037 | |
| Filed 2022-09-08 11:09 Tx date 2022-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,873 vol |
51,771 | |
| Filed 2022-06-23 11:55 Tx date 2022-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+16,898 vol |
16,898 | |
| Filed 2022-06-23 11:54 Tx date 2022-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|